ADVERTISEMENT
Image of the monocled cobra, a venomous cobra species.
pH-Engineered Venom-Fighting Antibodies
A combinatorial approach enabled researchers to develop antibodies with improved catch-and-release abilities against snake venom toxins.
pH-Engineered Venom-Fighting Antibodies
pH-Engineered Venom-Fighting Antibodies

A combinatorial approach enabled researchers to develop antibodies with improved catch-and-release abilities against snake venom toxins.

A combinatorial approach enabled researchers to develop antibodies with improved catch-and-release abilities against snake venom toxins.

monoclonal antibodies

Boosting the Efficiency of Therapeutic Antibody Development
Boosting the Efficiency of Therapeutic Antibody Development
The Scientist Staff | Jul 18, 2024 | 1 min read
In this webinar, Daryl Cole will highlight how new technologies improve antibody discovery and production.
Teaching Old Drugs New Tricks
Teaching Old Drugs New Tricks
The Scientist Staff | Jun 3, 2024 | 1 min read
Learn how scientists develop antibody drug conjugates as therapies for age-related diseases.   
Image showing monoclonal antibody treatment
The Resilience of Monoclonal Antibodies and their Makers
Laura Tran, PhD | Mar 15, 2024 | 10+ min read
The road to developing monoclonal antibodies for effectively targeting cancer was paved with tenacity, passion, and strokes of luck.
Building Broader B Cell Diversity for Better Monoclonal Antibody Discovery<br ><br>
Building Broader B Cell Diversity for Better Monoclonal Antibody Discovery
The Scientist Staff | Feb 5, 2024 | 1 min read
In this webinar, Vincent Pai will discuss how the latest automated single B cell functional screening technology helps researchers meet the demands for new monoclonal antibody candidates.
Infographic showing how a viral protein expression method links proteins and their coding instructions
Infographic: Phage Display Allows Rapid Screening of Millions of Peptides
Shelby Bradford, PhD | Dec 4, 2023 | 3 min read
A viral protein expression method links proteins and their coding instructions, enabling easier target identification for downstream analysis.
A Y-shaped pink, blue, and light green antibody is in focus on a background of blurred pink and purple color, with other antibodies out of focus in the background.
Phage Display: Finding the One in a Million
Shelby Bradford, PhD | Dec 4, 2023 | 10+ min read
A combinatorial approach enabled high-throughput screening of protein libraries for desired target binding.
A scientist not in frame is holding a plant leave with forceps in one hand and a petri dish with more leaves in the other.
Mean, Green, Antibody-producing Machines
Shelby Bradford, PhD | Dec 1, 2023 | 2 min read
A plant-based monoclonal antibody goes head-to-head with its commercial counterpart to target tumors in mice.
Accelerating Antibody Discovery for Difficult Targets
Accelerating Antibody Discovery for Difficult Targets
The Scientist | Sep 8, 2023 | 1 min read
François Romagné will discuss how RNA immunization and single cell screening enhance antibody generation for poorly immunogenic proteins.
T cell antigen binding site
Multiple Targets, Infinite Possibilities
The Scientist Staff | Aug 1, 2023 | 2 min read
Multispecific antibodies are rising stars in the field of antibody therapeutics, offering better specificity, targeting ability, and therapeutic effects than traditional monoclonal antibodies.
Abstract rendering of a tumor and its microenvironment in purple
The Basics of the Tumor Microenvironment
Johanna Pruller, PhD | Jun 15, 2023 | 4 min read
Learn about the tumor microenvironment (TME), a key influencer of cancer growth, spread, and treatment success.
Understanding Hybridoma Technology for Monoclonal Antibody Production
Understanding Hybridoma Technology for Monoclonal Antibody Production
Alpana Mohta, MD | May 9, 2023 | 5 min read
By fusing antibody-producing cells with immortal myeloma cells, researchers produce reliable supplies of highly specific antibodies.
3D rendered image of multiple antibody-drug conjugate next generation antibodies.
Advances in Antibody Therapeutics
Elina Kadriu | Apr 18, 2023 | 4 min read
Scientists engineer therapeutic antibodies with improved stability and efficacy. 
Achieve Comprehensive Analysis and Deeper Insight into Complex Biotherapeutics
High-Resolution Mass Spectrometry Solutions in Drug Discovery and Development
SCIEX | Jan 11, 2023 | 1 min read
Electron activated dissociation (EAD) and the Zeno trap provide high sensitivity and certainty in mass spectrometry results.
Learn about rapid cell screening for antibody therapeutic discovery
The Future of Antibody Discovery for Biotherapeutics
Sartorius | Dec 5, 2022 | 1 min read
Modern screening methods help usher in a new age of antibody therapeutics. 
Learn How the Immune System Can Be Trained to Overcome Food Allergies
Retraining the Immune System Cavalry for Food Allergen Peacekeeping Missions
The Scientist | Jul 25, 2022 | 1 min read
Explore food allergy immunotherapy for reversing patient symptoms.
Raising the Bar for Biomarkers and Early Diagnostics in Neurodegenerative Disease
Raising the Bar for Biomarkers and Early Diagnostics in Neurodegenerative Disease
Fortis Life Sciences | Jun 20, 2022 | 3 min read
Identifying novel biomarkers of Parkinson’s disease enables early diagnosis and treatment monitoring.
Illustration of a syringe with a person falling out of a bottle of pills
Opioid Vaccines as a Tool to Stem Overdose Deaths
Tori Rodriguez | Jun 13, 2022 | 10+ min read
Researchers are turning to the immune system for help in treating addiction and preventing overdose.
Artist’s rendering of a light purple Ebola virus looping around itself that’s surrounded by red blood cells
Ebola Lurking in Brain Fluid Kills Monkeys Weeks After Recovery
Dan Robitzski | Feb 9, 2022 | 4 min read
New research reveals where the virus was hiding and hints at how to truly purge it from the body.
Molecular Farming: The Future of Pharmaceuticals
The Scientist Speaks - Molecular Farming: The Future of Pharmaceuticals
Niki Spahich, PhD | Nov 16, 2021 | 1 min read
Julian Ma discusses past, present, and future uses of plant biotechnology for disease treatments.
ADVERTISEMENT